newsfilter
← Latest News
PR Newswire·

Dynavax to Report First Quarter 2025 Financial Results and Host Conference Call on May 6, 2025

Dynavax Technologies Corporation (NASDAQ: DVAX), a commercial stage biopharmaceutical company developing and commercializing innovative vaccines,...